Patent · US Active

Human Zika virus antibodies and methods of use therefor

US11021533B2 · kind B2 · utility

2Cited by
0References
20Claims
0Family size

Assignee

Inventor

Key dates

Filing dateNov 1, 2017
Grant dateJun 1, 2021
Priority date—
Expiry dateNov 1, 2037

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure is directed to antibodies binding to and neutralizing Zika virus and methods for use thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.